20
Participants
Start Date
November 1, 2018
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
cytotoxic t-lymphocytes
adenovirus specific cytotoxic t-lymphocytes will be collected and manufactured from HLA matched related or HLA mis-matched related donors and administered to eligible patients with refractory adenovirus or PID.
RECRUITING
Children's Hospital of Pennsylvania, Philadelphia
NOT_YET_RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Nationwide Children's Hosptial, Columbus
RECRUITING
Indiana University, Indianapolis
RECRUITING
Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee
RECRUITING
Washington University, St Louis
RECRUITING
Children's Hospital of Colorado, Aurora
RECRUITING
University of Colorado Denver, Aurora
RECRUITING
Children's Hospital Los Angeles, Los Angeles
RECRUITING
University of California San Francisco, San Francisco
Lead Sponsor
Children's Hospital of Philadelphia
OTHER
Medical College of Wisconsin
OTHER
Nationwide Children's Hospital
OTHER
Johns Hopkins University
OTHER
University of California, San Francisco
OTHER
University of Colorado, Denver
OTHER
Indiana University
OTHER
Washington University School of Medicine
OTHER
University of California, Los Angeles
OTHER
New York Medical College
OTHER